HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Madhukar Pai Selected Research

Interferon-gamma (Interferon, gamma)

10/2014Reproducibility of interferon gamma (IFN-╬│) release Assays. A systematic review.
1/2014A Bayesian framework for estimating the incremental value of a diagnostic test in the absence of a gold standard.
1/2014Gamma interferon release assays for detection of Mycobacterium tuberculosis infection.
11/2013Impact of blood volume, tube shaking, and incubation time on reproducibility of QuantiFERON-TB gold in-tube assay.
6/2013Trajectories of tuberculosis-specific interferon-gamma release assay responses among medical and nursing students in rural India.
2/2013Gamma interferon release assay for monitoring of treatment response for active tuberculosis: an explosion in the spaghetti factory.
1/2013Challenges in the development of an immunochromatographic interferon-gamma test for diagnosis of pleural tuberculosis.
12/2012Evaluation of the impact of interferon-gamma release assays on the management of childhood tuberculosis.
1/2012Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review.
1/2012TB screening in Canadian health care workers using interferon-gamma release assays.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Madhukar Pai Research Topics

Disease

37Tuberculosis (Tuberculoses)
04/2015 - 12/2004
16Latent Tuberculosis
10/2014 - 12/2004
15Infection
01/2014 - 12/2004
8Pulmonary Tuberculosis
01/2015 - 06/2007
5Pleural Tuberculosis
11/2013 - 10/2007
4HIV Infections (HIV Infection)
01/2014 - 06/2007
3Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
01/2014 - 10/2010
2Lymph Node Tuberculosis (Scrofula)
11/2007 - 10/2007
2Rheumatoid Nodule
11/2004 - 03/2004
1Malnutrition
05/2014
1Disease Progression
01/2012
1Extensively Drug-Resistant Tuberculosis
10/2010
1Multiple Organ Failure (MODS)
10/2010
1Stroke (Strokes)
06/2007
1Falciparum Malaria (Plasmodium falciparum Malaria)
06/2006
1Malaria
06/2006
1Cicatrix (Scar)
06/2005
1Vasculitis (Vasculitides)
11/2004
1Rheumatoid Vasculitis
11/2004
1Coronary Artery Disease (Coronary Atherosclerosis)
07/2004
1Obesity
07/2004
1Myocardial Infarction
07/2004
1Rheumatoid Arthritis
03/2004

Drug/Important Bio-Agent (IBA)

24Interferon-gamma (Interferon, gamma)IBA
10/2014 - 12/2004
17Tuberculin (PPD)IBA
01/2014 - 12/2004
10butyl 3-(1H-tetrazol-5-yl)oxanilate (MTB)IBA
02/2015 - 07/2011
9InterferonsIBA
05/2014 - 01/2009
8Rifampin (Rifampicin)FDA LinkGeneric
04/2015 - 01/2005
6AntigensIBA
05/2009 - 12/2004
4Isoniazid (Ftivazide)FDA LinkGeneric
04/2015 - 10/2010
4Biological Markers (Surrogate Marker)IBA
01/2013 - 05/2010
3Immunoglobulin G (IgG)IBA
11/2007 - 06/2007
2GoldIBA
02/2013 - 11/2011
2SmokeIBA
01/2012 - 02/2007
2Carbon MonoxideIBA
12/2010 - 10/2010
2HLA-DRB1 antigen (HLA DRB1)IBA
11/2004 - 03/2004
1FluoroquinolonesIBA
04/2015
1PyrazinamideFDA LinkGeneric
04/2015
1tetraphenylporphine sulfonate (TPPS)IBA
04/2015
1Complement System Proteins (Complement)IBA
05/2014
1VaccinesIBA
11/2013
1Adenosine DeaminaseIBA
01/2013
1AntibodiesIBA
05/2012
1insulin receptor-related receptor (IRR)IBA
01/2012
1Benzophenoneidum (Auramine O)IBA
05/2011
1AgarIBA
10/2010
1Rifabutin (Ansamycin)FDA Link
05/2010
1rifamycin SVIBA
05/2010
1sulfadoxine-pyrimethamine (Fansidar)FDA Link
06/2006
1Amodiaquine (Camoquin)FDA Link
06/2006
1Chloroquine (Aralen)FDA LinkGeneric
06/2006
1Mycobacterium tuberculosis antigensIBA
01/2006
1BCG VaccineFDA Link
06/2005
1Rheumatoid FactorIBA
11/2004
1Blood Glucose (Blood Sugar)IBA
07/2004

Therapy/Procedure

1Resuscitation
06/2007
1Aftercare (After-Treatment)
01/2006